首页|健脑增智饮对AD细胞模型的神经保护作用及对细胞凋亡的影响

健脑增智饮对AD细胞模型的神经保护作用及对细胞凋亡的影响

扫码查看
目的 探讨健脑增智饮对阿尔茨海默病(AD)细胞模型的神经保护作用及对细胞凋亡的影响。方法 将PC12 细胞用 20 μmol/L的β-淀粉样蛋白(Aβ)1-42 处理 24 h后分为六组:正常细胞对照组(NC组)、AD细胞模型组(AD组)、阳性药物对照AD组(AD+Donepezil组)、健脑增智饮(低浓度、中浓度、高浓度)治疗AD组(AD+5 μg/ml健脑增智饮组、AD+10 μg/ml健脑增智饮组、AD+20 μg/ml健脑增智饮组)。通过CCK-8 检测法检测细胞活性;通过western蛋白印迹法检测凋亡因子相关蛋白Bax、Bcl-2 的表达水平;应用流式细胞仪测定细胞凋亡情况。结果 通过CCK-8 检测法测定各组细胞活性结果显示:与NC组比较,AD组细胞活性显著降低(P<0。05);与AD组比较,AD+Donepezil组AD+20 μg/ml健脑增智饮组细胞活性显著增高(P<0。05)。通过western蛋白印迹法测定凋亡因子相关蛋白表达水平结果显示:与NC组比较,AD组Bax表达水平显著上调,Bcl-2 水平显著下调,Bcl-2/Bax显著下调(P<0。05);与AD组比较,AD+Donepezil组和AD+10 μg/ml健脑增智饮组、AD+20 μg/ml健脑增智饮组Bax水平显著下调(P<0。05),AD+Donepezil组和AD+20 μg/ml健脑增智饮组Bcl-2/Bax显著上调(P<0。05)。应用流式细胞仪测定细胞凋亡情况结果显示:NC组细胞凋亡率为(7。870±0。241)%,AD组为(36。530±1。429)%,AD+Donepezil组为(10。690±1。257)%,AD+5 μg/ml健脑增智饮组为(26。930±1。790)%,AD+10 μg/ml健脑增智饮组为(23。800±1。136)%,AD+20 μg/ml健脑增智饮组为(10。410±1。903)%。与NC组比较,AD组细胞凋亡率显著升高(P<0。05);与AD组比较,AD+Donepezil组和AD+5 μg/ml健脑增智饮组、AD+10 μg/ml健脑增智饮组、AD+20 μg/ml健脑增智饮组细胞凋亡显著降低(P<0。05)。结论 健脑增智饮可通过调控Bcl-2/Bax蛋白的表达,有效减少AD细胞的凋亡,提高细胞的活性,起到对AD细胞的神经保护作用,且高浓度(20 μg/ml)健脑增智饮治疗组疗效更优,为中医治疗认知障碍疾病的进一步探索提供理论及临床依据。
Effect of Jian Nao Zeng Zhi Yin on neuroprotection and apoptosis in AD cell model
Objective To investigate the neuroprotective effect of Jian Nao Zeng Zhi Yin on Alzheimer's disease(AD)cell model and its effect on apoptosis.Methods PC12 cells were treated with 20 μmol/L amyloid-β(Aβ1)-42 for 24 h and divided into six groups:normal cell control group(NC group),AD cell model group(AD group),positive drug control AD group(AD+Donepezil group)and Jian Nao Zeng Zhi Yin(low concentration,medium concentration and high concentration)treatment AD group(AD+5 μg/ml Jian Nao Zeng Zhi Yin group,AD+10 μg/ml Jian Nao Zeng Zhi Yin group,AD+20 μg/ml Jian Nao Zeng Zhi Yin group).Cell viability was detected by CCK-8 assay;the expression levels of apoptotic factor-related proteins Bax and Bcl-2 were detected by Western blotting;and apoptosis was determined by flow cytometry.Results The cellular activity was tested by CCK-8 assay,and the results showed that the cellular activity in AD group was significantly decreased compared with the NC group(P<0.05);compared with the AD group,the cellular activity in AD+Donepezil group,AD+20 μg/ml Jian Nao Zeng Zhi Yin group was also significantly increased(P<0.05).The expression levels of apoptotic factor-related proteins were tested by western blotting,and the results showed that the expression level of Bax was significantly up-regulated,Bcl-2 was significantly down-regulated and Bcl-2/Bax was significantly down-regulated in AD group compared with the NC group(P<0.05);compared with the AD group,Bax in AD+Donepezil group,AD+10 μg/ml Jian Nao Zeng Zhi Yin group and AD+20 μg/ml Jian Nao Zeng Zhi Yin group was significantly down-regulated,while Bcl-2/Bax in AD+Donepezil group and AD+20 μg/ml Jian Nao Zeng Zhi Yin group was significantly up-regulated(P<0.05).The apoptosis was tested by flow cytometry,and the results showed that the apoptosis rate was(7.870±0.241)%in NC group,(36.530±1.429)%in AD group,(10.690±1.257)%in AD+Donepezil group,(26.930±1.790)%in AD+5 μg/ml Jian Nao Zeng Zhi Yin group,(23.800±1.136)%in AD+10 μg/ml Jian Nao Zeng Zhi Yin group,(10.410±1.903)%in AD+20 μg/ml Jian Nao Zeng Zhi Yin group.Compared with the NC group,the apoptosis rate of AD group was significantly increased(P<0.05);compared with the AD group,the apoptosis rate of AD+5 μg/ml Jian Nao Zeng Zhi Yin group,AD+10 μg/ml Jian Nao Zeng Zhi Yin group and AD+20 μg/ml Jian Nao Zeng Zhi Yin group was significantly decreased(P<0.05).Conclusion Jian Nao Zeng Zhi Yin may reduce apoptosis of AD cell and increase cell viability by regulating the expression of Bcl-2/Bax protein,and play a neuroprotective role in AD cell model.High concentration(20 μg/ml)of Jian Nao Zeng Zhi Yin treatment group has a better efficacy,which can provide a theoretical and clinical basis for the further exploration of the traditional Chinese medicine treatment of cognitive disorders.

Jian Nao Zeng Zhi YinAlzheimer's diseaseNeuroprotectionApoptosis

杨玲、翁旭亮、曾婷、王成银、刘青、邱铃铃、雷源

展开 >

510000 广州医科大学附属中医医院脑病科

健脑增智饮 阿尔茨海默病 神经保护 细胞凋亡

广州医科大学附属中医医院中医药科研项目青苗计划广东省中医药局中医药科研项目

201900620201291

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(2)
  • 19